MACROGENICS INC — Director's Dealing 2019

Feb 25, 2019

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: MACROGENICS INC (MGNX)
CIK: 0001125345
Period of Report: 2019-02-21

Reporting Person: Wigginton Jon Marc (Sr VP, Clinical Dev. & CMO)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2019-02-21	Employee stock option (right to buy)	$21.88	A	90000	Acquired	2029-02-21	Common Stock (90000.0)	Direct

Footnotes

F1: 12.5% of the options become exercisable 6 months after the date of grant and the remaining 87.5% shall vest in 14 substantially equal quarterly installments thereafter.